Traws Pharma, Inc. ($TRAW)
Filing Information
| Accession Number | 0000947871-26-000481 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 29, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
3,586,374
Total Value
$998,207.43
P&L
-27.5% ($274,955.34)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Apr 16, 2026 | Purchase | 597,729 | $1.67 | $998,207.43 | 1,203,250 | Indirect | See Footnote | View Details | |
10% Owner | Series A Warrants (right to buy) | Derivative | Apr 16, 2026 | Purchase | 597,729 | โ | โ | 597,729 | Indirect | See Footnote | View Details | |
10% Owner | Series B Warrants (right to buy) | Derivative | Apr 16, 2026 | Purchase | 597,729 | โ | โ | 597,729 | Indirect | See Footnote | View Details | |
10% Owner | Series C Warrants (right to buy) | Derivative | Apr 16, 2026 | Purchase | 1,793,187 | โ | โ | 1,793,187 | Indirect | See Footnote | View Details |